Compass Therapeutics's total assets for Q3 2024 were $149.15M, a decrease of -4.15% from the previous quarter. CMPX total liabilities were $10.75M for the fiscal quarter, a 13.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.